The Valley Desk

NCT00790192 · Interventional trial

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Overall registry status Completed

Phase 3

Conditions Schizophrenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov